

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | heme biosynthetic process (GO:0006783) | 4.88512414 |
| 2 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.70290833 |
| 3 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.58939563 |
| 4 | Golgi transport vesicle coating (GO:0048200) | 4.58894791 |
| 5 | porphyrin-containing compound biosynthetic process (GO:0006779) | 4.47915459 |
| 6 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.21701145 |
| 7 | GDP-mannose metabolic process (GO:0019673) | 4.14951380 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.01358301 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.01358301 |
| 10 | heme metabolic process (GO:0042168) | 3.99607490 |
| 11 | tetrapyrrole biosynthetic process (GO:0033014) | 3.79749406 |
| 12 | porphyrin-containing compound metabolic process (GO:0006778) | 3.70239199 |
| 13 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.56844593 |
| 14 | maternal placenta development (GO:0001893) | 3.53336498 |
| 15 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.44038257 |
| 16 | erythrocyte maturation (GO:0043249) | 3.43841897 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.43446506 |
| 18 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.37539552 |
| 19 | hemoglobin metabolic process (GO:0020027) | 3.34429960 |
| 20 | neutrophil activation involved in immune response (GO:0002283) | 3.31875170 |
| 21 | regulation of early endosome to late endosome transport (GO:2000641) | 3.31640302 |
| 22 | protein retention in ER lumen (GO:0006621) | 3.26269034 |
| 23 | glucose catabolic process (GO:0006007) | 3.25795573 |
| 24 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.24691460 |
| 25 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.24691460 |
| 26 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.22728620 |
| 27 | NADPH regeneration (GO:0006740) | 3.18467658 |
| 28 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.18196573 |
| 29 | sequestering of actin monomers (GO:0042989) | 3.18151136 |
| 30 | proline biosynthetic process (GO:0006561) | 3.10749869 |
| 31 | barbed-end actin filament capping (GO:0051016) | 3.10583741 |
| 32 | pentose metabolic process (GO:0019321) | 3.10143421 |
| 33 | sulfur amino acid catabolic process (GO:0000098) | 3.09084618 |
| 34 | NADH metabolic process (GO:0006734) | 3.08032937 |
| 35 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.05019912 |
| 36 | NIK/NF-kappaB signaling (GO:0038061) | 2.98019982 |
| 37 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.96762802 |
| 38 | phospholipid efflux (GO:0033700) | 2.95922286 |
| 39 | pyrimidine nucleoside salvage (GO:0043097) | 2.91436958 |
| 40 | pyrimidine-containing compound salvage (GO:0008655) | 2.91436958 |
| 41 | mitotic nuclear envelope reassembly (GO:0007084) | 2.88356065 |
| 42 | nuclear envelope reassembly (GO:0031468) | 2.88356065 |
| 43 | virion assembly (GO:0019068) | 2.87440691 |
| 44 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.87386803 |
| 45 | cellular response to virus (GO:0098586) | 2.81717884 |
| 46 | plasma lipoprotein particle assembly (GO:0034377) | 2.80538695 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.79628371 |
| 48 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.78895401 |
| 49 | decidualization (GO:0046697) | 2.73910681 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 2.73704157 |
| 51 | negative regulation of sterol transport (GO:0032372) | 2.73704157 |
| 52 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.73468649 |
| 53 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.71505787 |
| 54 | protein-lipid complex assembly (GO:0065005) | 2.70791487 |
| 55 | natural killer cell differentiation (GO:0001779) | 2.70161711 |
| 56 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.69885793 |
| 57 | amyloid precursor protein catabolic process (GO:0042987) | 2.69700769 |
| 58 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.68402163 |
| 59 | regulation of cholesterol storage (GO:0010885) | 2.68274161 |
| 60 | regulation of superoxide anion generation (GO:0032928) | 2.67568296 |
| 61 | desmosome organization (GO:0002934) | 2.67502162 |
| 62 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.66968718 |
| 63 | protein insertion into membrane (GO:0051205) | 2.66946859 |
| 64 | platelet formation (GO:0030220) | 2.66620365 |
| 65 | detection of bacterium (GO:0016045) | 2.66373769 |
| 66 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.65296592 |
| 67 | immunoglobulin mediated immune response (GO:0016064) | 2.64911209 |
| 68 | negative regulation of cell size (GO:0045792) | 2.64336501 |
| 69 | viral protein processing (GO:0019082) | 2.63281483 |
| 70 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.63197041 |
| 71 | protein carboxylation (GO:0018214) | 2.63197041 |
| 72 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.62552168 |
| 73 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.62036250 |
| 74 | glucose 6-phosphate metabolic process (GO:0051156) | 2.61140465 |
| 75 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.60504770 |
| 76 | negative regulation of cell killing (GO:0031342) | 2.60504770 |
| 77 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.58088918 |
| 78 | modulation by virus of host process (GO:0019054) | 2.57838856 |
| 79 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.57775250 |
| 80 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.57585531 |
| 81 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.57425623 |
| 82 | positive regulation by symbiont of host defense response (GO:0052509) | 2.57228732 |
| 83 | modulation by symbiont of host defense response (GO:0052031) | 2.57228732 |
| 84 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.57228732 |
| 85 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.57228732 |
| 86 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.57228732 |
| 87 | modulation by symbiont of host immune response (GO:0052553) | 2.57228732 |
| 88 | regulation of cholesterol homeostasis (GO:2000188) | 2.57159536 |
| 89 | prostaglandin biosynthetic process (GO:0001516) | 2.57017437 |
| 90 | prostanoid biosynthetic process (GO:0046457) | 2.57017437 |
| 91 | deoxyribonucleotide catabolic process (GO:0009264) | 2.56134576 |
| 92 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.56062193 |
| 93 | low-density lipoprotein particle clearance (GO:0034383) | 2.53391332 |
| 94 | regulation of cholesterol esterification (GO:0010872) | 2.51533500 |
| 95 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.50942959 |
| 96 | amino sugar catabolic process (GO:0046348) | 2.50605845 |
| 97 | negative regulation of fibrinolysis (GO:0051918) | 2.48944298 |
| 98 | detection of other organism (GO:0098543) | 2.48328037 |
| 99 | nucleotide salvage (GO:0043173) | 2.47755153 |
| 100 | lipopolysaccharide metabolic process (GO:0008653) | 2.47649505 |
| 101 | plasma lipoprotein particle clearance (GO:0034381) | 2.47441236 |
| 102 | pinocytosis (GO:0006907) | 2.47103335 |
| 103 | deoxyribose phosphate catabolic process (GO:0046386) | 2.46928849 |
| 104 | positive thymic T cell selection (GO:0045059) | 2.46261585 |
| 105 | response to peptidoglycan (GO:0032494) | 2.45876918 |
| 106 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.45719772 |
| 107 | regulation of mitochondrial membrane potential (GO:0051881) | 2.45114963 |
| 108 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.44004772 |
| 109 | protein maturation by protein folding (GO:0022417) | 2.43421306 |
| 110 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.43213229 |
| 111 | positive regulation of reactive oxygen species metabolic process (GO:2000379) | 2.42048557 |
| 112 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.41940588 |
| 113 | glycosphingolipid catabolic process (GO:0046479) | 2.40396407 |
| 114 | positive regulation of lamellipodium assembly (GO:0010592) | 2.40204158 |
| 115 | activation of MAPKKK activity (GO:0000185) | 2.39971385 |
| 116 | regulation of autophagic vacuole assembly (GO:2000785) | 2.39604602 |
| 117 | platelet aggregation (GO:0070527) | 2.38897271 |
| 118 | respiratory burst (GO:0045730) | 2.38819989 |
| 119 | modulation by symbiont of host cellular process (GO:0044068) | 2.38343975 |
| 120 | mitochondrial calcium ion transport (GO:0006851) | 2.38186414 |
| 121 | response to type I interferon (GO:0034340) | 2.38036581 |
| 122 | monosaccharide biosynthetic process (GO:0046364) | 2.37672463 |
| 123 | L-phenylalanine metabolic process (GO:0006558) | 2.36574356 |
| 124 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.36574356 |
| 125 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.35979725 |
| 126 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.35360010 |
| 127 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.35049258 |
| 128 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.34981068 |
| 129 | regulation of erythrocyte differentiation (GO:0045646) | 2.34689741 |
| 130 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.34570315 |
| 131 | actin nucleation (GO:0045010) | 2.32634357 |
| 132 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.32586308 |
| 133 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.32078707 |
| 134 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.31810498 |
| 135 | actin filament polymerization (GO:0030041) | 2.31756660 |
| 136 | adenine nucleotide transport (GO:0051503) | 2.31107890 |
| 137 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.30954852 |
| 138 | type I interferon signaling pathway (GO:0060337) | 2.30698546 |
| 139 | cellular response to type I interferon (GO:0071357) | 2.30698546 |
| 140 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.30570542 |
| 141 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.30299898 |
| 142 | lipoxygenase pathway (GO:0019372) | 2.30269660 |
| 143 | leukocyte aggregation (GO:0070486) | 2.28614283 |
| 144 | establishment of viral latency (GO:0019043) | 2.28121967 |
| 145 | phagosome maturation (GO:0090382) | 2.28000319 |
| 146 | tricarboxylic acid metabolic process (GO:0072350) | 2.27723075 |
| 147 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.27453951 |
| 148 | negative regulation of B cell apoptotic process (GO:0002903) | 2.27080160 |
| 149 | UV protection (GO:0009650) | 2.26753872 |
| 150 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.25979704 |
| 151 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.25452538 |
| 152 | nitric oxide biosynthetic process (GO:0006809) | 2.25224193 |
| 153 | regulation of fibrinolysis (GO:0051917) | 2.24101194 |
| 154 | high-density lipoprotein particle remodeling (GO:0034375) | 2.22989808 |
| 155 | primary alcohol catabolic process (GO:0034310) | 2.22880800 |
| 156 | tetrapyrrole metabolic process (GO:0033013) | 2.22469352 |
| 157 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.21423361 |
| 158 | endothelial cell chemotaxis (GO:0035767) | 2.21415246 |
| 159 | apoptotic cell clearance (GO:0043277) | 2.21125225 |
| 160 | positive regulation of lipid catabolic process (GO:0050996) | 2.19609922 |
| 161 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.19404985 |
| 162 | cysteine metabolic process (GO:0006534) | 2.18281285 |
| 163 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.17845039 |
| 164 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.15811073 |
| 165 | acute-phase response (GO:0006953) | 2.15578706 |
| 166 | negative regulation of protein oligomerization (GO:0032460) | 2.14418498 |
| 167 | regulation of defense response to virus by virus (GO:0050690) | 2.14223095 |
| 168 | negative regulation of actin filament polymerization (GO:0030837) | 2.13909883 |
| 169 | pentose-phosphate shunt (GO:0006098) | 2.13371209 |
| 170 | 4-hydroxyproline metabolic process (GO:0019471) | 2.13238048 |
| 171 | regulation of ruffle assembly (GO:1900027) | 2.12592943 |
| 172 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.12368479 |
| 173 | cellular modified amino acid catabolic process (GO:0042219) | 2.11567917 |
| 174 | stress fiber assembly (GO:0043149) | 2.10164672 |
| 175 | urea metabolic process (GO:0019627) | 2.09449525 |
| 176 | urea cycle (GO:0000050) | 2.09449525 |
| 177 | positive regulation of nuclease activity (GO:0032075) | 2.08380741 |
| 178 | sexual reproduction (GO:0019953) | 2.08138000 |
| 179 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.07519183 |
| 180 | reactive oxygen species biosynthetic process (GO:1903409) | 2.06843135 |
| 181 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.06740445 |
| 182 | COPI coating of Golgi vesicle (GO:0048205) | 2.05899041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.87190208 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.43580606 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.84664856 |
| 4 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.83358951 |
| 5 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.63170727 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.56172937 |
| 7 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.54226283 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.52219585 |
| 9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.38004819 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.37830458 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.33174674 |
| 12 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.29568458 |
| 13 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.26063917 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.22529892 |
| 15 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.19903441 |
| 16 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.10454695 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.07194938 |
| 18 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05091966 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.03209473 |
| 20 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.97527437 |
| 21 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.93828749 |
| 22 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.89993224 |
| 23 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.85941833 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.85555033 |
| 25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.82678635 |
| 26 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.82206126 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.81895229 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 1.80009793 |
| 29 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.72795067 |
| 30 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.66520625 |
| 31 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.65817099 |
| 32 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.64808110 |
| 33 | GATA1_19941826_ChIP-Seq_K562_Human | 1.63230216 |
| 34 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.62935805 |
| 35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.62001231 |
| 36 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.60815574 |
| 37 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.60537431 |
| 38 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.58377747 |
| 39 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.57772464 |
| 40 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.56529491 |
| 41 | UTX_26944678_Chip-Seq_JUKART_Human | 1.56195412 |
| 42 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.55567771 |
| 43 | KDM2B_26808549_Chip-Seq_K562_Human | 1.54289182 |
| 44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.53484815 |
| 45 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.52653734 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.51782336 |
| 47 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.50503898 |
| 48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.50246094 |
| 49 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.49419161 |
| 50 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.48601122 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46294312 |
| 52 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.45344753 |
| 53 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.44518955 |
| 54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43793358 |
| 55 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.43210693 |
| 56 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.41273061 |
| 57 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.41204602 |
| 58 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.41101765 |
| 59 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.39825136 |
| 60 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.39775699 |
| 61 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.38756496 |
| 62 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.38646105 |
| 63 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37139948 |
| 64 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.36451432 |
| 65 | MAF_26560356_Chip-Seq_TH2_Human | 1.35415385 |
| 66 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.35153815 |
| 67 | ATF3_27146783_Chip-Seq_COLON_Human | 1.34567627 |
| 68 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.34563031 |
| 69 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30809941 |
| 70 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.30405924 |
| 71 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.29721698 |
| 72 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.29466301 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.29273195 |
| 74 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.29163431 |
| 75 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27427104 |
| 76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.27038542 |
| 77 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26831233 |
| 78 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.26179264 |
| 79 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25858594 |
| 80 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.25169243 |
| 81 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.24656583 |
| 82 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.24305797 |
| 83 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.24124714 |
| 84 | P68_20966046_ChIP-Seq_HELA_Human | 1.24118513 |
| 85 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.24109801 |
| 86 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.23742045 |
| 87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.23637748 |
| 88 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.23128461 |
| 89 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.22874294 |
| 90 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.20767439 |
| 91 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.20339754 |
| 92 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.19372331 |
| 93 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.18906834 |
| 94 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.18268510 |
| 95 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18025120 |
| 96 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.17425930 |
| 97 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17425271 |
| 98 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.17120017 |
| 99 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.16543122 |
| 100 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16345939 |
| 101 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.16264032 |
| 102 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15953733 |
| 103 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.15653230 |
| 104 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15124903 |
| 105 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.13926617 |
| 106 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.13514432 |
| 107 | SA1_27219007_Chip-Seq_Bcells_Human | 1.12104723 |
| 108 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.12081931 |
| 109 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.11688392 |
| 110 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10917129 |
| 111 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10063029 |
| 112 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.09325717 |
| 113 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.09221136 |
| 114 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09153618 |
| 115 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08648955 |
| 116 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.08101023 |
| 117 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.08050305 |
| 118 | GATA2_19941826_ChIP-Seq_K562_Human | 1.06642435 |
| 119 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.06181703 |
| 120 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.06045054 |
| 121 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06037149 |
| 122 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05728123 |
| 123 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.05306844 |
| 124 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.04819375 |
| 125 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.04328753 |
| 126 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.03940318 |
| 127 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.03804861 |
| 128 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.03715143 |
| 129 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03298123 |
| 130 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.03081201 |
| 131 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.02991431 |
| 132 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.01707833 |
| 133 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.01387431 |
| 134 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.01262877 |
| 135 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00963999 |
| 136 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00916180 |
| 137 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.00064741 |
| 138 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.97980066 |
| 139 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97585394 |
| 140 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.96897966 |
| 141 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.96395291 |
| 142 | SPI1_23127762_ChIP-Seq_K562_Human | 0.96167668 |
| 143 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.94953606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.74085241 |
| 2 | MP0008260_abnormal_autophagy | 3.69476778 |
| 3 | MP0005451_abnormal_body_composition | 3.66272048 |
| 4 | MP0005083_abnormal_biliary_tract | 3.56939154 |
| 5 | MP0003656_abnormal_erythrocyte_physiolo | 3.54628261 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 3.31779754 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 3.26871586 |
| 8 | MP0003436_decreased_susceptibility_to | 3.19726588 |
| 9 | MP0000685_abnormal_immune_system | 2.80293685 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 2.79677866 |
| 11 | MP0005360_urolithiasis | 2.74960340 |
| 12 | MP0004510_myositis | 2.70366767 |
| 13 | MP0009840_abnormal_foam_cell | 2.40329819 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.33989889 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.17669325 |
| 16 | MP0005085_abnormal_gallbladder_physiolo | 2.11611570 |
| 17 | MP0004858_abnormal_nervous_system | 1.94527482 |
| 18 | MP0009785_altered_susceptibility_to | 1.87544730 |
| 19 | MP0006082_CNS_inflammation | 1.85071869 |
| 20 | MP0003453_abnormal_keratinocyte_physiol | 1.82804169 |
| 21 | MP0004947_skin_inflammation | 1.76527136 |
| 22 | MP0003806_abnormal_nucleotide_metabolis | 1.75447350 |
| 23 | MP0005464_abnormal_platelet_physiology | 1.74779772 |
| 24 | MP0003724_increased_susceptibility_to | 1.71026444 |
| 25 | MP0005025_abnormal_response_to | 1.69091158 |
| 26 | MP0003075_altered_response_to | 1.64856367 |
| 27 | MP0000465_gastrointestinal_hemorrhage | 1.62039313 |
| 28 | MP0002822_catalepsy | 1.60159052 |
| 29 | MP0005058_abnormal_lysosome_morphology | 1.58651179 |
| 30 | MP0005365_abnormal_bile_salt | 1.58448026 |
| 31 | MP0005000_abnormal_immune_tolerance | 1.54737539 |
| 32 | MP0001835_abnormal_antigen_presentation | 1.51764275 |
| 33 | MP0000490_abnormal_crypts_of | 1.51639358 |
| 34 | MP0000858_altered_metastatic_potential | 1.50900091 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.49058766 |
| 36 | MP0005076_abnormal_cell_differentiation | 1.42468155 |
| 37 | MP0010329_abnormal_lipoprotein_level | 1.42397088 |
| 38 | MP0000609_abnormal_liver_physiology | 1.41030903 |
| 39 | MP0002796_impaired_skin_barrier | 1.39849736 |
| 40 | MP0005166_decreased_susceptibility_to | 1.38881843 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.38814705 |
| 42 | MP0005275_abnormal_skin_tensile | 1.34298529 |
| 43 | MP0001790_abnormal_immune_system | 1.33946340 |
| 44 | MP0005387_immune_system_phenotype | 1.33946340 |
| 45 | MP0008875_abnormal_xenobiotic_pharmacok | 1.33444128 |
| 46 | MP0003866_abnormal_defecation | 1.32579735 |
| 47 | MP0000678_abnormal_parathyroid_gland | 1.32505152 |
| 48 | MP0008961_abnormal_basal_metabolism | 1.30243890 |
| 49 | MP0001666_abnormal_nutrient_absorption | 1.29979321 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.28909928 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.28909928 |
| 52 | MP0005636_abnormal_mineral_homeostasis | 1.28024129 |
| 53 | MP0005671_abnormal_response_to | 1.25131071 |
| 54 | MP0000604_amyloidosis | 1.23817940 |
| 55 | MP0000681_abnormal_thyroid_gland | 1.23693891 |
| 56 | MP0001663_abnormal_digestive_system | 1.21900535 |
| 57 | MP0002419_abnormal_innate_immunity | 1.21035641 |
| 58 | MP0001853_heart_inflammation | 1.20698117 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.20196724 |
| 60 | MP0005501_abnormal_skin_physiology | 1.17368477 |
| 61 | MP0008469_abnormal_protein_level | 1.16885987 |
| 62 | MP0001348_abnormal_lacrimal_gland | 1.16194681 |
| 63 | MP0003283_abnormal_digestive_organ | 1.15850395 |
| 64 | MP0003329_amyloid_beta_deposits | 1.14992981 |
| 65 | MP0003566_abnormal_cell_adhesion | 1.13866818 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.13827864 |
| 67 | MP0008874_decreased_physiological_sensi | 1.13557986 |
| 68 | MP0002723_abnormal_immune_serum | 1.12798138 |
| 69 | MP0009764_decreased_sensitivity_to | 1.12516374 |
| 70 | MP0005165_increased_susceptibility_to | 1.12235043 |
| 71 | MP0002405_respiratory_system_inflammati | 1.11126980 |
| 72 | MP0002166_altered_tumor_susceptibility | 1.10295069 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 1.10181906 |
| 74 | MP0001819_abnormal_immune_cell | 1.08977631 |
| 75 | MP0002452_abnormal_antigen_presenting | 1.08887121 |
| 76 | MP0008438_abnormal_cutaneous_collagen | 1.08358333 |
| 77 | MP0002909_abnormal_adrenal_gland | 1.08290201 |
| 78 | MP0003183_abnormal_peptide_metabolism | 1.06970603 |
| 79 | MP0002148_abnormal_hypersensitivity_rea | 1.06922152 |
| 80 | MP0000750_abnormal_muscle_regeneration | 1.06049860 |
| 81 | MP0002420_abnormal_adaptive_immunity | 1.05682086 |
| 82 | MP0009333_abnormal_splenocyte_physiolog | 1.04681174 |
| 83 | MP0004859_abnormal_synaptic_plasticity | 1.03242059 |
| 84 | MP0000343_altered_response_to | 1.03159483 |
| 85 | MP0003448_altered_tumor_morphology | 1.02894857 |
| 86 | MP0008004_abnormal_stomach_pH | 1.02240350 |
| 87 | MP0005319_abnormal_enzyme/_coenzyme | 1.01772852 |
| 88 | MP0002877_abnormal_melanocyte_morpholog | 1.00992293 |
| 89 | MP0005381_digestive/alimentary_phenotyp | 0.99936521 |
| 90 | MP0001800_abnormal_humoral_immune | 0.99792529 |
| 91 | MP0009643_abnormal_urine_homeostasis | 0.98569031 |
| 92 | MP0002398_abnormal_bone_marrow | 0.98076844 |
| 93 | MP0009931_abnormal_skin_appearance | 0.97871911 |
| 94 | MP0006036_abnormal_mitochondrial_physio | 0.96646436 |
| 95 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.95406270 |
| 96 | MP0005390_skeleton_phenotype | 0.93256468 |
| 97 | MP0003252_abnormal_bile_duct | 0.93152298 |
| 98 | MP0002132_abnormal_respiratory_system | 0.92998841 |
| 99 | MP0000751_myopathy | 0.92684140 |
| 100 | MP0002249_abnormal_larynx_morphology | 0.92439212 |
| 101 | MP0009278_abnormal_bone_marrow | 0.92299935 |
| 102 | MP0005023_abnormal_wound_healing | 0.91260794 |
| 103 | MP0005310_abnormal_salivary_gland | 0.90977393 |
| 104 | MP0001905_abnormal_dopamine_level | 0.90792722 |
| 105 | MP0004185_abnormal_adipocyte_glucose | 0.89528150 |
| 106 | MP0001849_ear_inflammation | 0.89316480 |
| 107 | MP0002254_reproductive_system_inflammat | 0.86392401 |
| 108 | MP0003123_paternal_imprinting | 0.86390266 |
| 109 | MP0005666_abnormal_adipose_tissue | 0.86343005 |
| 110 | MP0002722_abnormal_immune_system | 0.85821710 |
| 111 | MP0000598_abnormal_liver_morphology | 0.84155656 |
| 112 | MP0002234_abnormal_pharynx_morphology | 0.83328222 |
| 113 | MP0002118_abnormal_lipid_homeostasis | 0.83204527 |
| 114 | MP0003186_abnormal_redox_activity | 0.82014129 |
| 115 | MP0000689_abnormal_spleen_morphology | 0.81476516 |
| 116 | MP0002429_abnormal_blood_cell | 0.81157778 |
| 117 | MP0002006_tumorigenesis | 0.81051562 |
| 118 | MP0003763_abnormal_thymus_physiology | 0.80938157 |
| 119 | MP0009053_abnormal_anal_canal | 0.80804658 |
| 120 | MP0002089_abnormal_postnatal_growth/wei | 0.79841299 |
| 121 | MP0000716_abnormal_immune_system | 0.78083364 |
| 122 | MP0005167_abnormal_blood-brain_barrier | 0.77679441 |
| 123 | MP0003172_abnormal_lysosome_physiology | 0.76952078 |
| 124 | MP0000703_abnormal_thymus_morphology | 0.76070286 |
| 125 | MP0002933_joint_inflammation | 0.75530989 |
| 126 | MP0010030_abnormal_orbit_morphology | 0.75471917 |
| 127 | MP0001873_stomach_inflammation | 0.75259489 |
| 128 | MP0000537_abnormal_urethra_morphology | 0.74955793 |
| 129 | MP0002998_abnormal_bone_remodeling | 0.72181987 |
| 130 | MP0006035_abnormal_mitochondrial_morpho | 0.71079886 |
| 131 | MP0009763_increased_sensitivity_to | 0.68380525 |
| 132 | MP0004381_abnormal_hair_follicle | 0.66234038 |
| 133 | MP0005375_adipose_tissue_phenotype | 0.66134605 |
| 134 | MP0001216_abnormal_epidermal_layer | 0.66088060 |
| 135 | MP0000920_abnormal_myelination | 0.65676412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.12830206 |
| 2 | Reticulocytosis (HP:0001923) | 4.01874657 |
| 3 | Eczematoid dermatitis (HP:0000976) | 3.98959803 |
| 4 | Polycythemia (HP:0001901) | 3.51196191 |
| 5 | Abnormality of macrophages (HP:0004311) | 3.44669948 |
| 6 | Poikilocytosis (HP:0004447) | 3.37068103 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.32002617 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.32002617 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 3.32002617 |
| 10 | Deep venous thrombosis (HP:0002625) | 3.27769076 |
| 11 | Hypercortisolism (HP:0001578) | 3.19994075 |
| 12 | Abnormality of the Achilles tendon (HP:0005109) | 3.11072933 |
| 13 | Achilles tendon contracture (HP:0001771) | 3.07166000 |
| 14 | Ragged-red muscle fibers (HP:0003200) | 2.97005196 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.95586118 |
| 16 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.95514226 |
| 17 | Xanthomatosis (HP:0000991) | 2.88670984 |
| 18 | Hyperbilirubinemia (HP:0002904) | 2.84421087 |
| 19 | Loss of speech (HP:0002371) | 2.83923357 |
| 20 | Hepatosplenomegaly (HP:0001433) | 2.80047746 |
| 21 | Late onset (HP:0003584) | 2.80028324 |
| 22 | Distal lower limb muscle weakness (HP:0009053) | 2.79170181 |
| 23 | Acanthocytosis (HP:0001927) | 2.77624003 |
| 24 | Protrusio acetabuli (HP:0003179) | 2.76979427 |
| 25 | Pustule (HP:0200039) | 2.73564536 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 2.72546064 |
| 27 | Obstructive lung disease (HP:0006536) | 2.72546064 |
| 28 | Multiple lipomas (HP:0001012) | 2.70688369 |
| 29 | Peritonitis (HP:0002586) | 2.65532260 |
| 30 | Cholelithiasis (HP:0001081) | 2.61384550 |
| 31 | Increased serum ferritin (HP:0003281) | 2.60198509 |
| 32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.59303929 |
| 33 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.55853617 |
| 34 | Increased cerebral lipofuscin (HP:0011813) | 2.54559810 |
| 35 | Myopathic facies (HP:0002058) | 2.51342641 |
| 36 | Progressive neurologic deterioration (HP:0002344) | 2.49015415 |
| 37 | Prolonged neonatal jaundice (HP:0006579) | 2.47982301 |
| 38 | Abnormality of complement system (HP:0005339) | 2.43957457 |
| 39 | Increased IgM level (HP:0003496) | 2.42912938 |
| 40 | Neuronal loss in central nervous system (HP:0002529) | 2.41298326 |
| 41 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.41112183 |
| 42 | Abnormal gallbladder morphology (HP:0012437) | 2.40526174 |
| 43 | Urticaria (HP:0001025) | 2.40404229 |
| 44 | Ankle clonus (HP:0011448) | 2.40290104 |
| 45 | Vertebral compression fractures (HP:0002953) | 2.39986474 |
| 46 | Supranuclear gaze palsy (HP:0000605) | 2.37954077 |
| 47 | J-shaped sella turcica (HP:0002680) | 2.36280953 |
| 48 | Abnormality of reticulocytes (HP:0004312) | 2.34783142 |
| 49 | Increased IgE level (HP:0003212) | 2.34384708 |
| 50 | Upper limb amyotrophy (HP:0009129) | 2.33316212 |
| 51 | Distal upper limb amyotrophy (HP:0007149) | 2.33316212 |
| 52 | Hyperparathyroidism (HP:0000843) | 2.32165252 |
| 53 | Systemic lupus erythematosus (HP:0002725) | 2.31266294 |
| 54 | Nasal polyposis (HP:0100582) | 2.28869283 |
| 55 | Insomnia (HP:0100785) | 2.28448837 |
| 56 | Joint hemorrhage (HP:0005261) | 2.28288315 |
| 57 | Hypertensive crisis (HP:0100735) | 2.24596788 |
| 58 | Interstitial pulmonary disease (HP:0006530) | 2.22246179 |
| 59 | Abnormality of iron homeostasis (HP:0011031) | 2.20266013 |
| 60 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.19319098 |
| 61 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.19319098 |
| 62 | Hand muscle atrophy (HP:0009130) | 2.17344429 |
| 63 | Abnormality of the nasal mucosa (HP:0000433) | 2.16248786 |
| 64 | Autoimmune thrombocytopenia (HP:0001973) | 2.15709815 |
| 65 | Menorrhagia (HP:0000132) | 2.12146330 |
| 66 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.11828873 |
| 67 | Mucopolysacchariduria (HP:0008155) | 2.11828873 |
| 68 | Vacuolated lymphocytes (HP:0001922) | 2.11357200 |
| 69 | Complement deficiency (HP:0004431) | 2.10315657 |
| 70 | Rhabdomyolysis (HP:0003201) | 2.09820298 |
| 71 | Myocardial infarction (HP:0001658) | 2.09664656 |
| 72 | Recurrent abscess formation (HP:0002722) | 2.09216877 |
| 73 | Gastrointestinal dysmotility (HP:0002579) | 2.08780594 |
| 74 | Dysostosis multiplex (HP:0000943) | 2.08443300 |
| 75 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.08290309 |
| 76 | Deep palmar crease (HP:0006191) | 2.07647266 |
| 77 | Myositis (HP:0100614) | 2.07562912 |
| 78 | Purpura (HP:0000979) | 2.06006873 |
| 79 | Fragile skin (HP:0001030) | 2.05802447 |
| 80 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.04693946 |
| 81 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.03659156 |
| 82 | Verrucae (HP:0200043) | 2.02977647 |
| 83 | Papilloma (HP:0012740) | 2.02977647 |
| 84 | Abnormal platelet function (HP:0011869) | 2.00063760 |
| 85 | Impaired platelet aggregation (HP:0003540) | 2.00063760 |
| 86 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.99721384 |
| 87 | Distal lower limb amyotrophy (HP:0008944) | 1.98132107 |
| 88 | Gastrointestinal infarctions (HP:0005244) | 1.98061503 |
| 89 | Petechiae (HP:0000967) | 1.96752821 |
| 90 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.95888279 |
| 91 | Meningitis (HP:0001287) | 1.93711992 |
| 92 | Neonatal onset (HP:0003623) | 1.93164827 |
| 93 | Epistaxis (HP:0000421) | 1.92580630 |
| 94 | Agammaglobulinemia (HP:0004432) | 1.92055651 |
| 95 | Woolly hair (HP:0002224) | 1.90590214 |
| 96 | Axonal loss (HP:0003447) | 1.90463160 |
| 97 | Right ventricular cardiomyopathy (HP:0011663) | 1.90376836 |
| 98 | Hypochromic anemia (HP:0001931) | 1.90360098 |
| 99 | Abnormal gallbladder physiology (HP:0012438) | 1.89521516 |
| 100 | Cholecystitis (HP:0001082) | 1.89521516 |
| 101 | Cerebral aneurysm (HP:0004944) | 1.87993345 |
| 102 | Gingivitis (HP:0000230) | 1.87952425 |
| 103 | Hypergammaglobulinemia (HP:0010702) | 1.87910200 |
| 104 | Conjunctival hamartoma (HP:0100780) | 1.85838022 |
| 105 | Cellulitis (HP:0100658) | 1.85494467 |
| 106 | Multiple enchondromatosis (HP:0005701) | 1.85158784 |
| 107 | Generalized hyperpigmentation (HP:0007440) | 1.85026538 |
| 108 | Recurrent bacterial skin infections (HP:0005406) | 1.84448627 |
| 109 | Hepatocellular carcinoma (HP:0001402) | 1.84256751 |
| 110 | Rough bone trabeculation (HP:0100670) | 1.84025694 |
| 111 | Amyloidosis (HP:0011034) | 1.83780040 |
| 112 | Trismus (HP:0000211) | 1.83686431 |
| 113 | Premature rupture of membranes (HP:0001788) | 1.83156953 |
| 114 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.83085264 |
| 115 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.83085264 |
| 116 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.83085264 |
| 117 | Stridor (HP:0010307) | 1.82761436 |
| 118 | Diminished motivation (HP:0000745) | 1.81733201 |
| 119 | Increased muscle lipid content (HP:0009058) | 1.81601340 |
| 120 | Glomerulonephritis (HP:0000099) | 1.81360737 |
| 121 | Paralysis (HP:0003470) | 1.80936123 |
| 122 | Ketosis (HP:0001946) | 1.80873537 |
| 123 | Hypertriglyceridemia (HP:0002155) | 1.80661843 |
| 124 | Exercise-induced myalgia (HP:0003738) | 1.80538314 |
| 125 | Abnormality of the gallbladder (HP:0005264) | 1.80405945 |
| 126 | Striae distensae (HP:0001065) | 1.79603603 |
| 127 | Genu recurvatum (HP:0002816) | 1.78125963 |
| 128 | Hypoglycemic coma (HP:0001325) | 1.77477696 |
| 129 | Abnormality of the common coagulation pathway (HP:0010990) | 1.76767247 |
| 130 | Microcytic anemia (HP:0001935) | 1.76722195 |
| 131 | Gastrointestinal inflammation (HP:0004386) | 1.76216842 |
| 132 | Muscle stiffness (HP:0003552) | 1.75504211 |
| 133 | Polygenic inheritance (HP:0010982) | 1.75311877 |
| 134 | Nonimmune hydrops fetalis (HP:0001790) | 1.75068197 |
| 135 | Acute hepatic failure (HP:0006554) | 1.74464219 |
| 136 | Cutaneous melanoma (HP:0012056) | 1.74303352 |
| 137 | Increased intramyocellular lipid droplets (HP:0012240) | 1.73850838 |
| 138 | Apathy (HP:0000741) | 1.72308357 |
| 139 | Fragile nails (HP:0001808) | 1.72007195 |
| 140 | Malnutrition (HP:0004395) | 1.71683980 |
| 141 | Recurrent fungal infections (HP:0002841) | 1.70654773 |
| 142 | Microvesicular hepatic steatosis (HP:0001414) | 1.70373840 |
| 143 | Broad distal phalanx of finger (HP:0009836) | 1.69678706 |
| 144 | Hyperacusis (HP:0010780) | 1.69531656 |
| 145 | Mediastinal lymphadenopathy (HP:0100721) | 1.69061024 |
| 146 | Fasciculations (HP:0002380) | 1.68214488 |
| 147 | Cerebral palsy (HP:0100021) | 1.68020019 |
| 148 | Lower limb hyperreflexia (HP:0002395) | 1.67956388 |
| 149 | Ketoacidosis (HP:0001993) | 1.67855227 |
| 150 | Growth hormone excess (HP:0000845) | 1.67303701 |
| 151 | Seborrheic dermatitis (HP:0001051) | 1.67123164 |
| 152 | Nuclear cataract (HP:0100018) | 1.66800887 |
| 153 | Erythema (HP:0010783) | 1.66300326 |
| 154 | Bulbar palsy (HP:0001283) | 1.65784365 |
| 155 | Abnormality of the motor neurons (HP:0002450) | 1.65617332 |
| 156 | Abnormal neuron morphology (HP:0012757) | 1.65617332 |
| 157 | Mutism (HP:0002300) | 1.65123556 |
| 158 | Asymmetric septal hypertrophy (HP:0001670) | 1.64843142 |
| 159 | Difficulty climbing stairs (HP:0003551) | 1.64261290 |
| 160 | Hypokinesia (HP:0002375) | 1.64047761 |
| 161 | Delusions (HP:0000746) | 1.61974011 |
| 162 | Neurofibrillary tangles (HP:0002185) | 1.60736243 |
| 163 | Hemorrhage of the eye (HP:0011885) | 1.59287970 |
| 164 | Myoglobinuria (HP:0002913) | 1.58854329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.27000047 |
| 2 | ERN1 | 4.11024030 |
| 3 | MAP3K10 | 3.42327436 |
| 4 | PKN2 | 2.64401749 |
| 5 | PRPF4B | 2.48503044 |
| 6 | SMG1 | 2.25055385 |
| 7 | VRK2 | 2.21355691 |
| 8 | TBK1 | 2.18123087 |
| 9 | KSR2 | 2.17261740 |
| 10 | GRK6 | 2.12440569 |
| 11 | CDK19 | 2.08282487 |
| 12 | PIM2 | 2.00769497 |
| 13 | TESK1 | 1.98163471 |
| 14 | ARAF | 1.94169111 |
| 15 | TAOK2 | 1.92439553 |
| 16 | TESK2 | 1.90093864 |
| 17 | MAP3K11 | 1.84384719 |
| 18 | FGFR4 | 1.83340217 |
| 19 | IRAK3 | 1.79943548 |
| 20 | BLK | 1.79842277 |
| 21 | MAP4K1 | 1.68727439 |
| 22 | TAOK1 | 1.65222968 |
| 23 | EPHB2 | 1.64366986 |
| 24 | RIPK4 | 1.63595473 |
| 25 | NME2 | 1.49433394 |
| 26 | EPHA2 | 1.48772881 |
| 27 | MAP2K2 | 1.33934680 |
| 28 | KDR | 1.28633853 |
| 29 | MAP3K1 | 1.25662973 |
| 30 | LIMK1 | 1.22876039 |
| 31 | BMX | 1.22810939 |
| 32 | EEF2K | 1.22289599 |
| 33 | DAPK2 | 1.22130295 |
| 34 | IKBKE | 1.21845189 |
| 35 | TYK2 | 1.21323055 |
| 36 | MAP3K3 | 1.20297917 |
| 37 | ZAP70 | 1.17925830 |
| 38 | ABL2 | 1.15718427 |
| 39 | DAPK3 | 1.15018729 |
| 40 | DYRK1B | 1.14044240 |
| 41 | EPHA3 | 1.11088423 |
| 42 | MAP3K2 | 1.08355144 |
| 43 | LRRK2 | 1.07889323 |
| 44 | JAK2 | 1.05047065 |
| 45 | RIPK1 | 1.03654465 |
| 46 | EPHB1 | 1.02938674 |
| 47 | BCKDK | 1.02866538 |
| 48 | IRAK4 | 1.01705471 |
| 49 | JAK3 | 1.01050254 |
| 50 | PTK6 | 1.01041946 |
| 51 | SCYL2 | 1.00555731 |
| 52 | MAP3K9 | 0.96636995 |
| 53 | MST1R | 0.94333136 |
| 54 | KSR1 | 0.92011802 |
| 55 | CSK | 0.90775701 |
| 56 | SIK1 | 0.89961517 |
| 57 | TNK2 | 0.89568521 |
| 58 | SIK2 | 0.88675650 |
| 59 | FES | 0.87976313 |
| 60 | MAPKAPK3 | 0.83236458 |
| 61 | MATK | 0.82716472 |
| 62 | MAP2K1 | 0.81260952 |
| 63 | NTRK1 | 0.81144605 |
| 64 | SYK | 0.79591688 |
| 65 | PRKD3 | 0.79564696 |
| 66 | ALK | 0.78564431 |
| 67 | RET | 0.76307365 |
| 68 | RAF1 | 0.76051771 |
| 69 | MAPK11 | 0.75032008 |
| 70 | HIPK2 | 0.73689787 |
| 71 | JAK1 | 0.73599718 |
| 72 | PRKG2 | 0.73392001 |
| 73 | PRKD2 | 0.73311859 |
| 74 | LMTK2 | 0.71288946 |
| 75 | PAK6 | 0.70647664 |
| 76 | GRK5 | 0.70077188 |
| 77 | MAP3K13 | 0.69245211 |
| 78 | ICK | 0.69196780 |
| 79 | CAMKK1 | 0.68657393 |
| 80 | PDGFRA | 0.65802283 |
| 81 | DAPK1 | 0.65279015 |
| 82 | DMPK | 0.63365670 |
| 83 | PTK2 | 0.63364914 |
| 84 | IKBKB | 0.63039532 |
| 85 | TGFBR2 | 0.62741531 |
| 86 | CSNK1G3 | 0.61659433 |
| 87 | IRAK2 | 0.60541072 |
| 88 | PIM1 | 0.60029662 |
| 89 | ILK | 0.59648629 |
| 90 | PAK4 | 0.58973258 |
| 91 | PAK1 | 0.58955000 |
| 92 | BRAF | 0.57741682 |
| 93 | FGFR3 | 0.57089085 |
| 94 | MAP3K12 | 0.56108978 |
| 95 | UHMK1 | 0.55918435 |
| 96 | CDK14 | 0.54496085 |
| 97 | AURKA | 0.54446824 |
| 98 | LATS2 | 0.53974427 |
| 99 | CDK11A | 0.53867212 |
| 100 | CAMK2G | 0.52007370 |
| 101 | STK10 | 0.51538855 |
| 102 | FLT3 | 0.50632663 |
| 103 | MINK1 | 0.50349713 |
| 104 | EPHA4 | 0.50305745 |
| 105 | MAPK15 | 0.50041977 |
| 106 | DDR2 | 0.47956240 |
| 107 | MAP3K6 | 0.47922594 |
| 108 | CDK15 | 0.47566667 |
| 109 | MAP3K8 | 0.47535063 |
| 110 | PDPK1 | 0.47214218 |
| 111 | FER | 0.46855642 |
| 112 | HCK | 0.45174262 |
| 113 | CDK18 | 0.44891970 |
| 114 | PRKCH | 0.44770335 |
| 115 | MUSK | 0.44374814 |
| 116 | MAP2K3 | 0.44053064 |
| 117 | MAP3K14 | 0.43199897 |
| 118 | RPS6KA1 | 0.41990528 |
| 119 | CSF1R | 0.41555980 |
| 120 | MAPKAPK2 | 0.40999109 |
| 121 | CCNB1 | 0.40963914 |
| 122 | BUB1 | 0.40744878 |
| 123 | DYRK3 | 0.39453061 |
| 124 | FGR | 0.38863758 |
| 125 | BTK | 0.38789947 |
| 126 | MOS | 0.38463142 |
| 127 | PTK2B | 0.38382793 |
| 128 | MARK2 | 0.38294845 |
| 129 | SIK3 | 0.37701314 |
| 130 | RPS6KC1 | 0.37080349 |
| 131 | RPS6KA4 | 0.35816741 |
| 132 | LYN | 0.34303318 |
| 133 | RPS6KA2 | 0.32902967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur relay system_Homo sapiens_hsa04122 | 3.43507558 |
| 2 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.61347850 |
| 3 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.32614672 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.29877474 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.28097155 |
| 6 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.26807364 |
| 7 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.17262799 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.15539948 |
| 9 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.92924127 |
| 10 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.92881402 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.92518529 |
| 12 | Bladder cancer_Homo sapiens_hsa05219 | 1.91512400 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.90861792 |
| 14 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.87920134 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.84564222 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.84123238 |
| 17 | Proteasome_Homo sapiens_hsa03050 | 1.82974032 |
| 18 | Base excision repair_Homo sapiens_hsa03410 | 1.72561482 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.64348585 |
| 20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.59550140 |
| 21 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.53658680 |
| 22 | Carbon metabolism_Homo sapiens_hsa01200 | 1.53542223 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.52453196 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.47439864 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.47092351 |
| 26 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.42590040 |
| 27 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.42402634 |
| 28 | Prion diseases_Homo sapiens_hsa05020 | 1.41452050 |
| 29 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.38701920 |
| 30 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.38588350 |
| 31 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.36202185 |
| 32 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.33827952 |
| 33 | Pertussis_Homo sapiens_hsa05133 | 1.32022861 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.30691511 |
| 35 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.29193387 |
| 36 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.25940791 |
| 37 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.25286389 |
| 38 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.24769819 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.24121601 |
| 40 | DNA replication_Homo sapiens_hsa03030 | 1.17053751 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.14399887 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 1.12244420 |
| 43 | * Endocytosis_Homo sapiens_hsa04144 | 1.11567933 |
| 44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.10852364 |
| 45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.10825441 |
| 46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.10649293 |
| 47 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.10200254 |
| 48 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.07405232 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.05691638 |
| 50 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.03975061 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.03376685 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.02744532 |
| 53 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.02655761 |
| 54 | Tuberculosis_Homo sapiens_hsa05152 | 1.02231890 |
| 55 | Bile secretion_Homo sapiens_hsa04976 | 0.99414870 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99127489 |
| 57 | Shigellosis_Homo sapiens_hsa05131 | 0.97474258 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97425682 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 0.97297305 |
| 60 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.95940916 |
| 61 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.95834186 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.94446078 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.94290356 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.94247655 |
| 65 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.93986493 |
| 66 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.93259563 |
| 67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92160863 |
| 68 | Legionellosis_Homo sapiens_hsa05134 | 0.91449831 |
| 69 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.90906256 |
| 70 | Parkinsons disease_Homo sapiens_hsa05012 | 0.90838109 |
| 71 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.90478277 |
| 72 | Glioma_Homo sapiens_hsa05214 | 0.90019021 |
| 73 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.85742910 |
| 74 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84671379 |
| 75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.84589157 |
| 76 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.84288814 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83999059 |
| 78 | Thyroid cancer_Homo sapiens_hsa05216 | 0.83522926 |
| 79 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.83141059 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83054488 |
| 81 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.82447218 |
| 82 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.79852113 |
| 83 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.78887460 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78732151 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.78480412 |
| 86 | Measles_Homo sapiens_hsa05162 | 0.78447469 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77803779 |
| 88 | Hepatitis B_Homo sapiens_hsa05161 | 0.77469970 |
| 89 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.76035694 |
| 90 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.75785360 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.74694156 |
| 92 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.73331621 |
| 93 | Ribosome_Homo sapiens_hsa03010 | 0.72985844 |
| 94 | Histidine metabolism_Homo sapiens_hsa00340 | 0.71968278 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71235472 |
| 96 | Malaria_Homo sapiens_hsa05144 | 0.71167606 |
| 97 | Lysosome_Homo sapiens_hsa04142 | 0.70437066 |
| 98 | Influenza A_Homo sapiens_hsa05164 | 0.70291904 |
| 99 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.70289052 |
| 100 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69719968 |
| 101 | Amoebiasis_Homo sapiens_hsa05146 | 0.69606487 |
| 102 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68998291 |
| 103 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.68866993 |
| 104 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.68625972 |
| 105 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66489025 |
| 106 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.66308332 |
| 107 | Hepatitis C_Homo sapiens_hsa05160 | 0.65132894 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65099065 |
| 109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63476414 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62177351 |
| 111 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61992323 |
| 112 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.61422764 |
| 113 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.60566336 |
| 114 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60242701 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57233927 |
| 116 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55932325 |
| 117 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.55195825 |
| 118 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54760668 |
| 119 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52949059 |
| 120 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.52323584 |
| 121 | Alzheimers disease_Homo sapiens_hsa05010 | 0.51147544 |
| 122 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49419996 |
| 123 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.48814297 |
| 124 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.48793494 |
| 125 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.48374887 |
| 126 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47977779 |
| 127 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.47938892 |
| 128 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.47858660 |
| 129 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.47320187 |
| 130 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.47218623 |
| 131 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46625666 |
| 132 | ABC transporters_Homo sapiens_hsa02010 | 0.46444149 |
| 133 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.46059894 |
| 134 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44900787 |
| 135 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44460553 |
| 136 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43678347 |
| 137 | Platelet activation_Homo sapiens_hsa04611 | 0.42282804 |
| 138 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.42098535 |
| 139 | Allograft rejection_Homo sapiens_hsa05330 | 0.40128670 |
| 140 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39700681 |
| 141 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36875779 |
| 142 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.36072618 |

